Dr. Linda Rehfeld has joined Arog Pharmaceuticals/ DAVA CRO as Clinical Research Scientist and
Mentrik Biotech as Project Manager in July 2019. Dr. Rehfeld brings 3 years of experience in
biomarker and therapeutic antibody development. Prior to joining Arog/ DAVA/ Mentrik Dr. Rehfeld
worked as Scientific Director at Sphingotec Therapeutics near Berlin, Germany. She received a PhD in
biochemistry and Alzheimer’s research, graduating summa cum laude from the Free University of
Berlin. She received her Bachelor and Master of Science in Molecular Biotechnology at the Technical
University of Munich.7